DiaMedica Therapeutics Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- DiaMedica Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $11.75M, a 68.12% decline year-over-year.
- DiaMedica Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $36.85M.
- DiaMedica Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $29.87M, a 40.95% increase year-over-year.
- DiaMedica Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $21.19M.
- DiaMedica Therapeutics Inc. stock issued during period, value, new issues for fiscal 2024 was $11.75M, a 68.12% decline from fiscal 2023.
- DiaMedica Therapeutics Inc. stock issued during period, value, new issues for fiscal 2023 was $36.85M.
- DiaMedica Therapeutics Inc. stock issued during period, value, new issues for fiscal 2021 was $29.85M, a 3.62% increase from fiscal 2020.
- DiaMedica Therapeutics Inc. stock issued during period, value, new issues for fiscal 2020 was $28.80M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $11.75M 10-K · filed 2025-03-17 | |
| 2024-06-30 | $11.75M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $36.85M 10-K · filed 2025-03-17 | |
| 2023-06-30 | $36.85M 10-Q · filed 2024-11-13 | |
| 2021-12-31 | $29.85M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $29.87M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $28.80M 10-K · filed 2022-03-14 | |
| 2020-09-30 | $21.19M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | |
| 2020-03-31 | $7.68M 10-Q · filed 2021-11-10 | |
| 2018-12-31 | $14.73M 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |